Oncostatin M Receptor anticorps
Aperçu rapide pour Oncostatin M Receptor anticorps (ABIN709616)
Antigène
Voir toutes Oncostatin M Receptor (OSMR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human Oncostatin-M receptor
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB(1:100-1000), IHC-P(1:100-500), IF(IHC-P)(1:50-200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for 12 months.
-
Date de péremption
- 12 months
-
-
- Oncostatin M Receptor (OSMR)
-
Autre désignation
- Osmr
-
Sujet
-
Synonyms: Oncostatin M receptor, Oncostatin M specic receptor subunit beta, Interleukin-31 receptor subunit beta, IL-31 receptor subunit beta, IL-31R subunit beta, IL-31R-beta, IL-31RB, Oncostatin-M-specic receptor, beta, OSMRB, MGC140467, MGC150626, MGC150627, MGC75127.
Background: Oncostatin M is a member of the IL6 family of cytokines. Functional receptors for IL6 family cytokines are multisubunit complexes involving members of the hematopoietin receptor superfamily. Many IL6 cytokines utilize gp130 as a common receptor subunit. OSM binds to the gp130 receptor subunit and, in association with the leukemia inhibitory factor receptor, induces a proliferative response in permissive cells. OSMR is an alternative subunit (for an OSM receptor complex (a heterodimer of gp130 and OSMR) that is activated by OSM but not by LIF.
-
ID gène
- 157869
-
Pathways
- Signalistation JAK/STAT, Growth Factor Binding
Antigène
-